Advertisement

Spectrofluorimetric Characterization of Serum Pentosidine and Retinol Binding Protein in Healthy Rats and Rats with Streptozotocin-Induced Diabetes

  • D. M. Ciobanu
  • L. E. OlarEmail author
  • R. Ştefan
  • G. Roman
  • I. Papuc
Conference paper
Part of the IFMBE Proceedings book series (IFMBE, volume 71)

Abstract

Recently, the fluorescence techniques have become increasingly important in medical diagnostics. Moreover, there is a growing need to introduce cost-effective and no time-consuming techniques for the investigation of various fluorophores in humans and animals with diabetes mellitus. In the studied literature, the newly diagnosis of diabetes mellitus and, subsequently, the risk of developing diabetes complications are reported to be correlated with the production of serum fluorophores pentosidine and retinol binding protein. As far as we are aware, there has been no study on the simultaneous fluorescence evaluation of pentosidine and retinol binding protein in biological fluids obtained from animals. In the present study, the emission intensity and levels of serum pentosidine and retinol binding protein were monitored in both healthy rats and rats with streptozotocin-induced diabetes. The results showed that the height of the peak at ~382 nm attributed to the presence of pentosidine in the serum, and the height of the peak at ~465 nm attributed to retinol binding protein in the serum were significantly higher in rats with streptozotocin-induced diabetes compared to healthy control rats. Also, their contributions to the total fluorescence of serum were significantly higher in rats with streptozotocin-induced diabetes compared to healthy control rats. Thus, fluorescence spectroscopy might be a reliable and useful technique that can be successfully applied in the evaluation and monitoring of serum pentosidine and retinol binding protein in both healthy rats and rats with streptozotocin-induced diabetes.

Keywords

Pentosidine Retinol binding protein Diabetes mellitus Rats Fluorescence spectroscopy 

Notes

Acknowledgements

The work was supported by an internal grant (4994/3/08.03.2016) financed by the Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca.

Conflict of Interest

The authors declare that they have no potential conflict of interest relevant to this article.

References

  1. 1.
    O’Neill, D.G., Gostelow, R., Orme, C., et al.: Epidemiology of Diabetes Mellitus among 193,435 cats attending primary care veterinary practices in England. J. Vet. Int. Med. 30(4), 964–972 (2016).  https://doi.org/10.1111/jvim.14365CrossRefGoogle Scholar
  2. 2.
    Cho, N.H., Shaw, J.E., Karuranga, S., et al.: IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 138, 271–281 (2018).  https://doi.org/10.1016/j.diabres.2018.02.023CrossRefGoogle Scholar
  3. 3.
    Kerkeni, M., Saïdi, A., Bouzidi, H., et al.: Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients. Diab. Vasc. Dis. Res. 10(3), 239–245 (2013).  https://doi.org/10.1177/1479164112460253CrossRefGoogle Scholar
  4. 4.
    Ram, J., Snehalatha, C., Selvam, S., et al.: Retinol binding protein-4 predicts incident diabetes in Asian Indian men with prediabetes. BioFactors 41(3), 160–165 (2015).  https://doi.org/10.1002/biof.1209CrossRefGoogle Scholar
  5. 5.
    Rhee, E.J., Plutzky, J.: Retinoid Metabolism and Diabetes Mellitus. Diabetes Metab. J. 36(3), 167–180 (2012).  https://doi.org/10.4093/dmj.2012.36.3.167CrossRefGoogle Scholar
  6. 6.
    Tanaka, M.: Relationship between urinary pentosidine concentration and vascular complications in type 2 diabetic patients. J Diabetes Metab. 7, 640 (2016).  https://doi.org/10.4172/2155-6156.1000640CrossRefGoogle Scholar
  7. 7.
    Cabré, A., Lázaro, I., Girona, J., et al.: Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes. J. Intern. Med. 262(4), 496–503 (2007)CrossRefGoogle Scholar
  8. 8.
    Novery, E., Susanah, S., Rachmadi, D.: The Correlation of urine retinol binding protein-4 and serum HbA1c with glomerular filtration rate in type 1 (insulin-dependent) diabetic children: a perspective on the duration of diabetes. Open J. Pediatrics 05(2), 134–140 (2015).  https://doi.org/10.4236/ojped.2015.52020CrossRefGoogle Scholar
  9. 9.
    Grandhee, S.K., Monnier, V.M.: Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. J. Biol. Chem. 266(18), 11649–11653 (1991)Google Scholar
  10. 10.
    Sternberg, M., M’bemba, J., Urios, P., et al.: Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6 years after punch-biopsy. Clin. Biochem. 49(3), 225–231 (2016).  https://doi.org/10.1016/j.clinbiochem.2015.10.011CrossRefGoogle Scholar
  11. 11.
    Rabbani, N., Thornalley, P.J.: Hidden complexities in the measurement of fructosyl-lysine and advanced glycation end products for risk prediction of vascular complications of diabetes. Diabetes 64(1), 9–11 (2015).  https://doi.org/10.2337/db14-1516CrossRefGoogle Scholar
  12. 12.
    Requena, J.R., Price, D.L., Thorpe, S.R., Baynes, J.W.: Measurement of pentosidine in biological samples. Aging Methods Protoc. 38, 209–217 (2000).  https://doi.org/10.1385/1-59259-070-5:209CrossRefGoogle Scholar
  13. 13.
    Tanumihardjo, S.A.: Assessing vitamin A status: past, present and future. J. Nutr. 134(1), 290S–293S (2004)CrossRefGoogle Scholar
  14. 14.
    Raghu, P., Sivakumar, B.: Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis. Biochimica et Biophysica Acta (BBA)—Proteins Proteomics 1703(1), 1–9 (2004).  https://doi.org/10.1016/j.bbapap.2004.09.023CrossRefGoogle Scholar
  15. 15.
    Silvaroli, J.A., Arne, J.M., Chelstowska, S., et al.: Ligand binding induces conformational changes in human cellular Retinol-binding Protein 1 (RETINOL BINDING PROTEIN 1) revealed by atomic resolution crystal structures. J. Biol. Chem. 29(16), 8528–8540 (2016).  https://doi.org/10.1074/jbc.M116.714535CrossRefGoogle Scholar
  16. 16.
    Berry, D.C., Croniger, C.M., Ghyselinck, N.B., et al.: Transthyretin blocks retinol uptake and cell signaling by the holo-retinol-binding protein receptor STRA6. Mol. Cell. Biol. 32(19), 3851–3859 (2012).  https://doi.org/10.1128/MCB.00775-12CrossRefGoogle Scholar
  17. 17.
    Monaco, H.L.: The transthyretin-retinol-binding protein complex. Biochimica et Biophysica Acta (BBA)—Protein Struct. Mol. Enzymol. 1482(1–2), 65–72 (2000).  https://doi.org/10.1016/s0167-4838(00)00140-0CrossRefGoogle Scholar
  18. 18.
    Futterman, S., Swanson, D., Kalina, R.E.: A new, rapid fluorometric determination of retinol in serum. Invest Ophthalmol. 14(2), 125–130 (1975)Google Scholar
  19. 19.
    Kawaguchi, R., Zhong, M., Sun, H.: Real-time analyses of retinol transport by the membrane receptor of plasma retinol binding protein. J. Visualized Exp. JoVE 71, e50169 (2013).  https://doi.org/10.3791/50169CrossRefGoogle Scholar
  20. 20.
    Kraft, R., Herndon, D.N., Kulp, G.A. et al.: Retinol binding protein: marker for insulin resistance and inflammation postburn? JPEN. J. Parenteral Enteral Nutr. 35(6) (2011).  https://doi.org/10.1177/0148607111413901
  21. 21.
    Klisić, A., Kavarić, N., Bjelaković, B., et al.: The association between retinol-binding protein 4 and cardiovascular risk score is mediated by waist circumference in overweight/obese adolescent girls. Acta Clin. Croat. 56(1), 92–98 (2017).  https://doi.org/10.20471/acc.2017.56.01.14CrossRefGoogle Scholar
  22. 22.
    Kim, Y.S., Kim, N.H., Lee, S.W., et al.: Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats. Eur. J. Pharmacol. 569(3), 171–179 (2007)CrossRefGoogle Scholar
  23. 23.
    Séro, L., Sanguinet, L., Blanchard, P., et al.: Tuning a 96-well microtiter plate fluorescence-based assay to identify AGE inhibitors in crude plant extracts. Molecules 18(11), 14320–14339 (2013).  https://doi.org/10.3390/molecules181114320CrossRefGoogle Scholar
  24. 24.
    Takahashi, M., Oikawa, M., Nagano, A.: Effect of age and menopause on serum concentrations of pentosidine, an advanced glycation end product. J Gerontol A 55(3), M137–M140 (2000).  https://doi.org/10.1093/gerona/55.3.M137CrossRefGoogle Scholar
  25. 25.
    Olar, L.E., Ciobanu, D.M., Matei, F., Papuc, I.: The assessment of fluorophores advanced glycation end products-to-kynurenine ratio in healthy and diabetic rats and humans. Studia. UBB Chemia. 63(1), 37–53 (2018).  https://doi.org/10.24193/subbchem.2018.1.03CrossRefGoogle Scholar
  26. 26.
    Sugiyama, S., Miyata, T., Ueda, Y., et al.: Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J. Am. Soc. Nephrol. 9(9), 1681–1688 (1998)Google Scholar
  27. 27.
    Machowska, A., Sun, J., Qureshi, A.R et al. Plasma pentosidine and its association with mortality in patients with chronic kidney disease. PLoS one 4; 11(10): e0163826 (2016).  https://doi.org/10.1371/journal.pone.0163826
  28. 28.
    Chang, Y.H., Lin, K.D., Wang, C.L., et al.: Elevated serum retinol-binding protein 4 concentrations are associated with renal dysfunction and uric acid in type 2 diabetic patients. Diabetes Metab. Res. Rev. 24(8), 629–634 (2008).  https://doi.org/10.1002/dmrr.894CrossRefGoogle Scholar
  29. 29.
    Abahusain, M.A., Wright, J., Dickerson, J.W.: Retinol, alpha-tocopherol and carotenoids in diabetes. Eur. J. Clin. Nutr. 53(8), 630–635 (1999)CrossRefGoogle Scholar
  30. 30.
    Tuitoek, P.J., Ziari, S., Tsin, A.T., et al.: Streptozotocin-induced diabetes in rats is associated with impaired metabolic availability of vitamin A (retinol). Br. J. Nutr. 75(4), 615–622 (1996)CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • D. M. Ciobanu
    • 1
  • L. E. Olar
    • 2
    Email author
  • R. Ştefan
    • 2
  • G. Roman
    • 1
  • I. Papuc
    • 2
  1. 1.Iuliu Haţieganu University of Medicine and PharmacyCluj-NapocaRomania
  2. 2.University of Agricultural Sciences and Veterinary MedicineCluj-NapocaRomania

Personalised recommendations